Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DORMAZOLAM - Health Canada Drug Approval Details

Approvals/Health Canada/DORMAZOLAM

Authorized

STANDARD

DORMAZOLAM

DECHRA REGULATORY BV🇨🇦 Health Canada

Approval Date: Feb 6, 2026
Approval ID: 05068452ed29668f
Company: DECHRA REGULATORY BV
Type: Standard

Approval Details

Approval Id: 05068452ed29668f
Drug Approval Canada Name: DORMAZOLAM
Product Name: DORMAZOLAM
Status: Marketed
Status Date: 2021-12-21
Original Market Date: 2021-12-21
Drug Class: Veterinary
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: TARGETED SUBSTANCES (CDSA IV)
Atc Original: Not Applicable
Aig Number: 0119935001
Company Name: DECHRA REGULATORY BV
Company Address: Handelsweg 25 Bladel -- Netherlands 5531 AE

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Feb 6, 2026

Approval ID

05068452ed29668f

Type

Standard

Back to Health Canada Approvals